Bedrosian Camille L - Insider Non-Derivative Transactions at Ultragenyx Pharmaceutical Inc. (RARE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 1, 2023, Bedrosian Camille L's relationship to Ultragenyx Pharmaceutical Inc. (RARE) is Officer (EVP and Chief Medical Officer), and currently has 50,601 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RARE insiders.
Data Source: SEC.
Bedrosian Camille L - Insider Non-Derivative Transactions at RARE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 2, 2023 | Sell -- (Common Stock) | 3881 | 45.25 | 46720 |
| Mar 2, 2023 | Acquisition -- (Common Stock) | 2663 | 0 | 50601 |